TrialNature medicine2024

Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial.

Peter G M de Gooyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.